Skip to main content
An official website of the United States government
The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Search:
Agenda
Reg Review
ICR
This script is used to control the display of information in this page.
Display additional information by clicking on the following:
All
Brief and OIRA conclusion
Abstract/Justification
Legal Statutes
Rulemaking
FR Notices/Comments
IC List
Burden
Misc.
Common Form Info.
Certification
View Information Collection (IC) List
View Supporting Statement and Other Documents
Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.
View ICR - OIRA Conclusion
OMB Control No:
0910-0625
ICR Reference No:
201904-0910-010
Status:
Historical Active
Previous ICR Reference No:
201603-0910-006
Agency/Subagency:
HHS/FDA
Agency Tracking No:
CDRH
Title:
Electronic Submission of Medical Device Registration and Listing
Type of Information Collection:
Extension without change of a currently approved collection
Common Form ICR:
No
Type of Review Request:
Regular
OIRA Conclusion Action:
Approved without change
Conclusion Date:
06/17/2019
Retrieve Notice of Action (NOA)
Date Received in OIRA:
05/21/2019
Terms of Clearance:
Inventory as of this Action
Requested
Previously Approved
Expiration Date
06/30/2022
36 Months From Approved
06/30/2019
Responses
186,230
0
180,585
Time Burden (Hours)
93,798
0
99,470
Cost Burden (Dollars)
0
0
0
Abstract:
This information collection request covers the reporting and recordkeeping provisions associated with FDA's implementation of sections 222, 223, and 224 of the Food and Drug Administration Amendments Act of 2007 (FDAAA), which require that device establishment registrations and listings under section 21 U.S.C. 360(p) (including the submission of updated information) be submitted to the Secretary by electronic means, unless the Secretary grants a request for waiver of the requirement because the use of electronic means is not reasonable for the person requesting the waiver.
Authorizing Statute(s):
US Code:
21 USC 510(j)(2)
US Code:
21 USC 510(p)
US Code:
21 USC 510(b)
Citations for New Statutory Requirements:
None
Associated Rulemaking Information
RIN:
Stage of Rulemaking:
Federal Register Citation:
Date:
Not associated with rulemaking
Federal Register Notices & Comments
60-day Notice:
Federal Register Citation:
Citation Date:
83 FR 62583
12/04/2018
30-day Notice:
Federal Register Citation:
Citation Date:
84 FR 20138
05/08/2019
Did the Agency receive public comments on this ICR?
No
Number of Information Collection (IC) in this ICR:
18
IC Title
Form No.
Form Name
Annual Registration
FDA 3673
FDA 3673
Annual Registration & Listing when Electronic Filing Waiver granted (recurring)
Annual Request for Waiver from Electronic Registration & Listing (one time)
Annual Submittal of Manufacturer Information by Initial Importers (recurring)
Annual Update of Changes to US Agent Information
FDA 3673
FDA 3673
Annual Update of Listing Information
FDA 3673
FDA 3673
Creation of electronic system account
Identification of initial importers by foreign establishments
FDA 3673
FDA 3673
Identification of other parties that facilitate import by foreign establishments
Initial Registration & Listing
FDA 3673
FDA 3673
Initial Registration & Listing when Electronic Filing Waiver Granted (one time)
Initial Request for Waiver from Electronic Registration & Listing (recurring)
Intitial Submittal of Manufacturer Information by Initial Importers (One time)
Labeling & Advertisement Submitted at FDA Request
Labeling & Advertisements Available for Review
List of Officers, Directors and Partners
Other Updates of Registration
US Agent Responses to FDA Requests for Information
ICR Summary of Burden
Total Approved
Previously Approved
Change Due to New Statute
Change Due to Agency Discretion
Change Due to Adjustment in Estimate
Change Due to Potential Violation of the PRA
Annual Number of Responses
186,230
180,585
0
0
5,645
0
Annual Time Burden (Hours)
93,798
99,470
0
0
-5,672
0
Annual Cost Burden (Dollars)
0
0
0
0
0
0
Burden increases because of Program Change due to Agency Discretion:
No
Burden Increase Due to:
Burden decreases because of Program Change due to Agency Discretion:
No
Burden Reduction Due to:
Short Statement:
The following adjustments resulted in a 5,672-hour decrease to the overall total hour burden estimate for this ICR. -We adjusted the number of respondents based on updated registration and listing data. -In the reporting burden table, we corrected the table footnotes to accurately indicate whether the IC is a one-time or reoccurring burden. -We also adjusted some of the IC descriptions in the table for increased clarity. -We updated our estimate of Hours per Response for “807.22(a) Initial Registration & Listing” (+0.5 hours), “807.22(b)(1) Annual Registration” (-0.25 hours), and “807.22(b)(3) Annual Update of Listing Information” (-0.25 hours). Based on our review of the program, we believe these changes to the burden estimate will more accurately reflect the current preparation time for these ICs.
Annual Cost to Federal Government:
$540,610
Does this IC contain surveys, censuses, or employ statistical methods?
No
Does this ICR request any personally identifiable information (see
OMB Circular No. A-130
for an explanation of this term)? Please consult with your agency's privacy program when making this determination.
Yes
Does this ICR include a form that requires a Privacy Act Statement (see
5 U.S.C. §552a(e)(3)
)? Please consult with your agency's privacy program when making this determination.
No
Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]?
No
Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]?
No
Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)?
No
Is this ICR related to the Pandemic Response?
Uncollected
Agency Contact:
Amber Sanford 301 796-8867 amber.sanford@fda.hhs.gov
Common Form ICR:
No
On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
(a) It is necessary for the proper performance of agency functions;
(b) It avoids unnecessary duplication;
(c) It reduces burden on small entities;
(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
(f) It indicates the retention periods for recordkeeping requirements;
(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control number;
(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
(i) It uses effective and efficient statistical survey methodology (if applicable); and
(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date:
05/21/2019
An official website of the United States government
The .gov means it's official.
The site is secure.
